NO984572D0 - Anvendelse av 2,5-dihydroksybenzensulfonderivater for fremstilling av legemidler ment for normalisering av den endoteliale funksjon, for behandling av seksuell dysfunksjon og vaskulµre komplikasjoner i diabetes, sÕvel som vaskulµre lidelser av e - Google Patents

Anvendelse av 2,5-dihydroksybenzensulfonderivater for fremstilling av legemidler ment for normalisering av den endoteliale funksjon, for behandling av seksuell dysfunksjon og vaskulµre komplikasjoner i diabetes, sÕvel som vaskulµre lidelser av e

Info

Publication number
NO984572D0
NO984572D0 NO984572A NO984572A NO984572D0 NO 984572 D0 NO984572 D0 NO 984572D0 NO 984572 A NO984572 A NO 984572A NO 984572 A NO984572 A NO 984572A NO 984572 D0 NO984572 D0 NO 984572D0
Authority
NO
Norway
Prior art keywords
vascular
dihydroxybenzenesulfone
normalization
diabetes
derivatives
Prior art date
Application number
NO984572A
Other languages
English (en)
Other versions
NO323015B1 (no
NO984572L (no
Inventor
Josu Esteve-Soler
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9604182A external-priority patent/FR2747040B1/fr
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of NO984572D0 publication Critical patent/NO984572D0/no
Publication of NO984572L publication Critical patent/NO984572L/no
Publication of NO323015B1 publication Critical patent/NO323015B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19984572A 1996-04-03 1998-09-30 Anvendelse av 2,5-dihydroksybenzensulfonderivater for fremstilling av legemidler ment for normalisering av den endoteliale funksjon, for behandling av seksuell dysfunksjon NO323015B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9604182A FR2747040B1 (fr) 1996-04-03 1996-04-03 Derives 2,5-dihydroxybenzenesulfoniques comme medicaments pour normaliser la fonction endotheliale et la fonction sexuelle, et traiter les troubles vasculaires d'origine diabetique ou endotheliale
PCT/EP1997/001709 WO1997037647A1 (fr) 1996-04-03 1997-04-03 Utilisation des derives 2,5-dihydroxybenzenesulfoniques pour la fabrication de medicaments destines a la normalisation de la fonction endotheliale, pour le traitement de la dysfonction sexuelle et des complications vasculaires du diabete, ainsi que des troubles vasculaires d'origine endotheliale

Publications (3)

Publication Number Publication Date
NO984572D0 true NO984572D0 (no) 1998-09-30
NO984572L NO984572L (no) 1998-09-30
NO323015B1 NO323015B1 (no) 2006-12-27

Family

ID=26070196

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984572A NO323015B1 (no) 1996-04-03 1998-09-30 Anvendelse av 2,5-dihydroksybenzensulfonderivater for fremstilling av legemidler ment for normalisering av den endoteliale funksjon, for behandling av seksuell dysfunksjon

Country Status (9)

Country Link
US (1) US6147112A (no)
EP (1) EP0954298B1 (no)
JP (1) JP2000508308A (no)
AU (1) AU715600B2 (no)
BR (1) BR9708595A (no)
CA (1) CA2251226C (no)
DE (1) DE69735417T2 (no)
NO (1) NO323015B1 (no)
WO (1) WO1997037647A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403643B1 (en) * 1997-04-03 2002-06-11 Laboratories Del Dr. Esteve, S.A. Use of 2,5-dihydroxybenzenesulfonic derivatives for the normalization of endothelial function
ES2180446B1 (es) * 2001-07-02 2004-01-16 Esteve Labor Dr Empleo de derivados de acidos 2,5-dihidroxibencenosulfonicos en la elaboracion de un medicamento para potenciar el efecto de otros farmacos en el tratamiento de la disfuncion erectil.
ES2208124B1 (es) * 2002-11-29 2005-10-01 Laboratorios Del Dr. Esteve, S.A. Uso de los compuestos 2,5-dihidroxibencenosulfonicos para la fabricacion de un medicamento.
ES2208123A1 (es) * 2002-11-29 2004-06-01 Laboratorios Del Dr. Esteve, S.A. Uso de los compuestos 2,5-dihidroxibencenosulfonicos para la fabricacion de un medicamento.
ES2229902B1 (es) * 2003-05-23 2006-06-01 Laboratorios Del Dr. Esteve, S.A. Uso de compuestos 2,5 - dihidroxibencenosulfonicos para la fabricacion de un medicamento.
ES2222831B2 (es) * 2003-07-30 2006-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de principio activo que comprende un compuesto 2,5-dihidroxibencenosulfonico y un modulador de los canales de k+.
LT5474B (lt) 2006-04-12 2008-02-25 Laboratorios Del Dr. Esteve, S. A. 2,5-dihidroksibenzensulfoninių junginių panaudojimas sutrikimų, paremtų no produkcijos susilpnėjimu, gydymui ir/arba edhf funkcijos reguliavimui
US9012692B2 (en) * 2008-01-03 2015-04-21 AmDerma Pharmaceuticals, LLC Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts
CN110092736A (zh) * 2018-12-05 2019-08-06 湖北广辰药业有限公司 一种减少羟苯双磺酸钙杂质含量的羟苯磺酸钙制备方法
CN110123776A (zh) * 2019-05-17 2019-08-16 贵州天安药业股份有限公司 一种高效微血管循环改善的羟苯磺酸钙胶囊
EP3878837A1 (en) 2020-03-11 2021-09-15 OM Pharma SA 2,5- or 2,6-disubstituted hydroquinone derivatives with at least one carboxy, sulfo or amido group useful as medicaments

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204506A1 (es) * 1972-05-17 1976-02-12 Esteve Labor Dr Procedimiento de preparacion de sales de acidos p-dihidroxibencenodisulfonicos
US4038390A (en) * 1972-05-17 1977-07-26 Laboratorios Del Dr. Esteve, S.A. Salts of p-dihydroxybenzene disulfonic acids for combatting hemorrhages and fragility of the capillaries
US3947448A (en) * 1972-05-17 1976-03-30 Laboratorios Del Dr. Esteve Sa Salts of novel p-dihydroxybenezene disulfonic acids
US4513007A (en) * 1983-05-03 1985-04-23 Laboratoires Om Sa Method for treating heart disease

Also Published As

Publication number Publication date
US6147112A (en) 2000-11-14
AU715600B2 (en) 2000-02-03
AU2693697A (en) 1997-10-29
WO1997037647A1 (fr) 1997-10-16
EP0954298A1 (fr) 1999-11-10
EP0954298B1 (fr) 2006-03-08
DE69735417D1 (de) 2006-05-04
NO323015B1 (no) 2006-12-27
JP2000508308A (ja) 2000-07-04
CA2251226A1 (fr) 1997-10-16
DE69735417T2 (de) 2006-09-21
CA2251226C (fr) 2007-09-11
NO984572L (no) 1998-09-30
BR9708595A (pt) 1999-08-03

Similar Documents

Publication Publication Date Title
HUP0100069A3 (en) 4(3)substituted-4(3)-aminomethyl-pyran, or -thiopyran-piperidine derivatives, their preparation and their use in the treatment of neurological disorders
EP1600169A3 (en) A pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders
HUP0004439A3 (en) 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
NO20004098D0 (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
NO972972D0 (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
EP2087892A3 (en) (S,S) reboxetine for treating age associated learning and mental disorders
NO963568D0 (no) Farmasöytisk preparat for behandling av blodkoagulasjonssykdommer, fremgangsmåter for fremstilling av dette og dets anvendelse
NO20001754D0 (no) Prostaglandinagonister og anvendelse derav for behandling av benforstyrrelser
ATE232865T1 (de) 1,4-diazabicyclo(3.2.2)nonan-4-carboxylat und carboxamidderivate, ihre herstellung und therapeutische verwendung
CA2387873A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
NO20032636D0 (no) 3-indolinderivater som er nyttige i behandlingen av psykiatriske og nevrologiske forstyrrelser
CA2385410A1 (en) Sapogenin derivatives and their use in the treatment of cognitive dysfunction
CA2294921A1 (en) Levobupivacaine and its use
NO984572L (no) Anvendelse av 2,5-dihydroksybenzensulfonderivater for fremstilling av legemidler ment for normalisering av den endoteliale funksjon, for behandling av seksuell dysfunksjon og vaskulµre komplikasjoner i diabetes, sÕvel som vaskulµre lidelser av e
EE04493B1 (et) Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
ITMI992107A0 (it) Uso del baclofen nel trattamento dell'astinenza da etanolo
ZA97741B (en) Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders.
AU4312593A (en) Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease
CA2347863A1 (en) Treatment of disorders of the outer retina
DE69808921D1 (de) 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOL-1-ACETAMID-DERIVATE, IHRE HERSTELLUNG UND THERAPEUTISCHE ANWENDUNG
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
PT932400E (pt) Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
CA2260863A1 (en) Treatment of psychotic disorders